SB

Subramanya Boddanapalli Venkata Prasad

Active Director Additional Director DIN 11458247
DIN 11458247 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Subramanya Boddanapalli Venkata Prasad

Data last updated:

Subramanya Boddanapalli Venkata Prasad is an Additional Director at Oxiant Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11458247
Primary Designation Additional Director
Industry Pharma
First Appointment 02 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director02 Jan 2026Active

Board colleagues of Subramanya Boddanapalli Venkata Prasad

NameDINCompanyDesignation
Padmaja Vepakomma08898480Oxiant Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oxiant Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Subramanya Boddanapalli Venkata Prasad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subramanya Boddanapalli Venkata Prasad

Subramanya Boddanapalli Venkata Prasad currently holds 1 directorship: Oxiant Pharmaceuticals Private Limited (Additional Director, since 02 Jan 2026).

Subramanya Boddanapalli Venkata Prasad was first appointed on 02 Jan 2026 as Additional Director at Oxiant Pharmaceuticals Private Limited.

The current boards of Subramanya Boddanapalli Venkata Prasad's companies include Padmaja Vepakomma (Oxiant Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available